Assessing Women's Preferences for Postpartum Thromboprophylaxis: the Prefer-Postpartum Study
NCT ID: NCT05897697
Last Updated: 2023-06-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
122 participants
OBSERVATIONAL
2021-09-24
2022-10-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Mother-Infant Intervention for Postpartum Depression and Associated Mother-Infant Relationship Dysfunction
NCT02057627
1 Day Workshops for Preventing PPD: A Pilot Study
NCT05040581
Blood Pressure Monitoring in Postpartum Women at Risk of Hypertension
NCT05457504
Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial
NCT05655936
Screening for Postpartum Depression and Associated Risk Factors Among Women Who Deliver in Four Hospital in France During the COVID-19 Epidemic
NCT04487171
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pregnant / postpartum women
Adult women during pregnancy or the early postpartum period (within 7 days of delivery)
Interview
Structured interview
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Interview
Structured interview
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ongoing pregnancy or within 7 days of delivery
* fluency in French or English
Exclusion Criteria
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Marc Blondon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Marc Blondon
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Justine Hugon-Rodin
Paris, , France
Marc Blondon
Geneva, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UGeneva 2021-01336
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.